Cancer BiologybioRxivPreprint
Biologically-informed machine learning identifies a new clinically-actionable bladder cancer subgroup characterised by NRF2 overactivity
Vlad V. Ungureanu, Richard T. Gawne, Simon C. Baker…·Andrew S. Mason
The paper uses biologically-informed machine learning to identify a new bladder cancer subgroup with NRF2 overactivity, which is clinically actionable and resistant to standard treatments.
DOI 10.1101/2025.06.03.657659